Labshake search
Citations for Tocris :
251 - 300 of 721 citations for 7 Chloro trans 2 hepenoic acid ethyl ester since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Neuroscience 2023Quote: Glutamate was photolysed from MNI-Glutamate (4-Methoxy-7-nitroindolinyl-caged-L-glutamate; Tocris Biotechne, UK) with a 405 nm laser (Obis ...
-
bioRxiv - Neuroscience 2019Quote: ... Mice were then injected intraperitoneally with kainic acid (Tocris biosciences, cat. # 0222) dissolved in PBS pH
-
bioRxiv - Neuroscience 2020Quote: ... and the glutamate receptor antagonist kynurenic acid (3 mM KynA, Tocris Bioscience) was included in the external solution to isolate GABA currents ...
-
bioRxiv - Biochemistry 2022Quote: ... 6,8-Bis[(phenylmethyl)thio]octanoic acid (CPI 613, Tocris Bioscience, Cat# 5348), a PDH and KGDH inhibitor ...
-
bioRxiv - Neuroscience 2021Quote: ... Stock solution (25 mM) of Ginkgolic acid (GA, no. 6326, Tocris Bioscience) was prepared in DMSO ...
-
bioRxiv - Neuroscience 2021Quote: ... Animals first received 10 mg/kg of kainic acid (Tocris Bioscience, UK) mixed in 1x PBS (8 ml per 10 mg ...
-
bioRxiv - Neuroscience 2020Quote: ... animals were exposed to 10mM 6-OHDA/2mM ascorbic acid (Tocris Bioscience) for one-hour at 20°C ...
-
bioRxiv - Neuroscience 2022Quote: ... 20 μM CNQX and 5 μM 5,7-DiCl-kynurenic acid (Tocris, UK). For whole-cell GABAR-mediated currents ...
-
bioRxiv - Neuroscience 2023Quote: ... 1 μM retinoic acid (STEMCELL) and 500 mg/ml cyclic AMP (Tocris), with medium changes three times a week.
-
Autism genes converge on microtubule biology and RNA-binding proteins during excitatory neurogenesisbioRxiv - Systems Biology 2024Quote: ... 0.2mM ascorbic acid) containing small molecules 1uM PD0325901 (P)(Tocris, Cat#4192), 5uM SU5402 (SU)(MilliporeSigma ...
-
bioRxiv - Cell Biology 2021Quote: ... 2-APB (Tocris), Xestospongin C (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 20 μM of 2,3-dihydroxy 6-nitro-7-sulfamoyl-benzoquinoxaline-2,3-dione (NBQX, 1044, Tocris Bioscience, UK), 25 μM of d-(-)-2-amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Cancer Biology 2022Quote: Pancreatitis was induced by 7 intraperitoneal injections of cerulein (50 μg/kg; Tocris Bioscience, cat#62-641) at hourly intervals on two alternating days ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were split 12–30 h after transfection and plated on glass coverslips in the presence of 50 μM NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide; Tocris Bioscience) to avoid AMPAR-mediated toxicity ...
-
bioRxiv - Neuroscience 2021Quote: ... SR95531 (gabazine) and 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate) were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2024Quote: ... IPSCs were recorded in the presence of 10µM CNQX (6-cyano-7-nitroquinoxaline-2,3-dione, Tocris 1045) and 50µM D-AP5 (D-2-amino-5-phosphonovalerate ...
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Neuroscience 2024Quote: ... All networks received a 20-min 50 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, in DMSO; Tocris, #0373) treatment on top of that ...
-
bioRxiv - Animal Behavior and Cognition 2022Quote: ... (R)-(+)-WIN 55,212-2) WIN 55,212-2 was purchased from Tocris Cookson Ltd ...
-
bioRxiv - Biochemistry 2023Quote: ... 5% CO2 with either DMSO or MLi-2 (Tocris; 2 μM) for 1 hour ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs were first treated with the sialic acid inhibitor P-3FAX-Neu5Ac (Tocris) for 24 hours ...
-
bioRxiv - Neuroscience 2019Quote: ... at concentrations of 34 μM and 340 μM and dihydrokainic acid (DHK) (Tocris), an excitatory amino acid 2 (EAAT2 ...
-
bioRxiv - Microbiology 2021Quote: ... 1 mM orange-red TAMRA-based fluorescent D-amino acid (RADA, Tocris, 6649) was added to the µ-dish ...
-
bioRxiv - Neuroscience 2024Quote: ... or kainic acid (1mg/ml dissolved in sterile saline, Tocris; Catalog No: 0222), were injected into the lateral habenula ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide disodium salt (NBQX; #1044) and Kainate (KA; #0222) were purchased from Tocris. L-Glutamic acid monosodium salt (Glu ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Neuroscience 2019Quote: ... N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide (ANA12, 10 µM) (Tocris), (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3’,2’,1’-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester (K252a ...
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Neuroscience 2022Quote: ... or 20 μM 2-methylthyo-adenosine-5’-triphosphate (2-MeSATP, Tocris, 1062) over a 5-min period ...
-
bioRxiv - Systems Biology 2019Quote: ... 2μM IWP-2 (Tocris) and 10μM DAPT [goblet and enteroendocrine cells] (25).
-
bioRxiv - Neuroscience 2021Quote: ... MLi-2 (Tocris #5756) was reconstituted in DMSO to a stock concentration of 10mM ...
-
bioRxiv - Neuroscience 2022Quote: ... WIN55,212-2 (1038, Tocris), and Torin 2 (4248 ...
-
bioRxiv - Cell Biology 2020Quote: ... MLi-2 (Tocris, 5756) was used at 1 µM ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: WIN55,212-2 (Tocris, #1038), α-Humulene (Sigma Aldrich ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin-2 (Tocris 4248), rapamycin (CalBiochem 553211) ...
-
bioRxiv - Cell Biology 2019Quote: ... and IWP-2 (Tocris) were added at 3µM and 1µM ...
-
bioRxiv - Cell Biology 2023Quote: ... 2 µM Dorsomorphin (TOCRIS) and 2 µM XAV939 (Stemgent) ...
-
bioRxiv - Physiology 2023Quote: ... 2 μM PD0332991 (Tocris), 10 ng/ml human BDNF (Miltenyi Biotec) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 µM CHIR99021 (Tocris) and 5µM Y27632 (Santa Cruz) ...
-
bioRxiv - Neuroscience 2024Quote: ... DMH1 (2 μM, Tocris) and SB431542 (2 μM ...
-
bioRxiv - Cell Biology 2023Quote: ... 2 µM Dorsomorphin (Tocris), 10 µM SB-431542 (Tocris) ...
-
bioRxiv - Cancer Biology 2024Quote: ... AKTi-1/2 (Tocris), MK-2206 (VWR) ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Cell Biology 2019Quote: ... HeLa FRT cells were released from thymidine block (40 h after siRNA treatment) for 7 hours before arresting at the G2/M boundary with RO-3306 treatment (10μM, Tocris) for 2 hours ...